Early Detection of Liver Cancer Needs Reliable Biomarkers

by Rajshri on  February 27, 2010 at 8:53 PM Research News
  •   Print
  •   Share
  •   Comments
  •  Text 
Neither des-gamma-carboxy prothrombin (DCP) nor the most widely used biomarker, alpha fetoprotein (AFP) is optimal for detecting liver cancer, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

"Most surprising was the finding that patient demographics influenced both des-gamma-carboxy prothrombin and alpha fetoprotein values, but in opposite directions," said Anna S. Lok, MD, AGAF, of the University of Michigan Medical Center and lead author of the study. "This observation merits further investigation, as it might impact the accuracy of these biomarkers in the detection of liver cancer."

The study was conducted in 10 centers in the U.S. and funded by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Among 1,031 patients randomized in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial, a nested case-control study of 39 HCC cases (24 early stage) and 77 matched controls was conducted to compare the performance of AFP and DCP. Testing was performed on serial serum samples collected during a 12-month period prior to the time of HCC diagnosis. Study results indicated that:

  • The sensitivity and specificity of DCP at month 0 (at the time of HCC diagnosis) was 74 percent and 86 percent at a cutoff of 40 mAU/mL, and 43 percent and 100 percent at a cutoff of 150 mAU/mL.
  • The sensitivity and specificity of AFP at month 0 was 61 percent and 81 percent at a cutoff of 20 ng/mL, and 22 percent and 100 percent at a cutoff of 200 ng/mL.
  • At month -12 (12 months before the diagnosis of HCC), the sensitivity and specificity at the low cutoff was 43 percent and 94 percent for DCP, and 47 percent and 75 percent for AFP.
  • Combining both markers increased the sensitivity to 91 percent at month 0 and 73 percent at month -12, but the specificity decreased to 74 percent and 71 percent.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Cancer
Looking for information on cancer? Go through medindia's Cancer quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cancer
Complete Medindia Resources
News Categories:  
Diabetes Health Center

Research Related News

» Lack of Vitamin D in Diet Raises Stroke Risk in Japanese-Americans » Why Bovine TB Continues to Spread Demystified in New Research
» Seaweed Pill May Help Treat Arthritis » P. Aeruginosa Infection Leads to Worse Outcomes and Increased Hospitalizations in COPD Patients
» Hormone Boosts Production of Molecules Which Fight Skin Infection » Protein Discovery Could Lead To New Vaccine for Meningitis
» Qui Vive: Intense Nuclear Radiation Threat, Scientists » 'Miracle' Diet of Reverse Engineering Epilepsy
Read More >>